Vaccine : Actualité Vaccine en direct - P1 | Bourse Reflex
Accueil > Tags > Vaccine

  • Toutes les actualités en rapport avec « Vaccine »

28/02 11:50 Vaccine - OCTOPUS ROBOTS: 1st AgTech listed on the Paris Stock Exchange Listing by technical admission on Euronext AccessTM the14th of March 2018

20/02 16:45 Vaccine - OCTOPUS ROBOTS: Plan to Seek a Listing on the Compartment of Euronext Access Paris

28/02 17:45 Vaccine - Genticel becomes Genkyotex: Genticel's General Meeting approves the strategic combination with GenKyoTex SA

28/02 08:30 Vaccine - GENTICEL ANNOUNCES ITS 2016 ANNUAL RESULTS

16/02 18:20 Vaccine - Genticel updates its financial calendar for 2017

30/01 18:00 Vaccine - BUSINESS UPDATE - FOURTH QUARTER 2016

25/01 18:00 Vaccine - GENTICEL ANNOUNCES ITS FINANCIAL CALENDAR FOR 2017

03/01 18:00 Vaccine - Disclosure of the total number of voting rights and shares composing the share capital

03/01 18:00 Vaccine - SUMMARY OF GENTICEL'S LIQUIDITY CONTRACT WITH ODDO CORPORATE FINANCE

22/12 13:00 Vaccine - Genticel and Genkyotex Announce Intention to Enter into Strategic Combination

13/12 18:30 Vaccine - GENTICEL REPORTS FINAL RESULTS OF GTL001 PHASE 2 TRIAL IN HPV16/18-INFECTED WOMEN

30/11 08:00 Vaccine - GENTICEL successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines

27/10 18:35 Vaccine - BUSINESS UPDATE - THIRD QUARTER 2016

22/09 19:00 Vaccine - GENTICEL PRESENTS FIRST HALF 2016 FINANCIAL RESULTS AND UPDATES ITS OPERATIONAL OUTLOOK

08/08 18:35 Vaccine - Disclosure of the total number of voting rights and shares composing the share capital

08/08 18:35 Vaccine - HALF-YEAR SUMMARY OF GENTICEL'S LIQUIDITY CONTRACT WITH ODDO CORPORATE FINANCE

28/07 18:35 Vaccine - ACTIVITÉ DU DEUXIÈME TRIMESTRE 2016

28/07 18:35 Vaccine - BUSINESS UPDATE - SECOND QUARTER 2016

07/07 19:30 Vaccine - Disclosure of the total number of voting rights and shares composing the share capital

06/07 18:35 Vaccine - GENTICEL APPOINTS EUMEDIX AS STRATEGIC ADVISOR TO SUPPORT COMPANY'S ACCESS TO INNOVATIVE DRUG CANDIDATES